SCHEMBL7670561

SCHEMBL7670561

CC(=C(NC(=O)c1cccnc1Cl)C(=O)O)c1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 2/20 0.44
EGFR P00533 4/20 0.41
ALDH1A1 P00352 3/20 0.41
NPC1 O15118 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ITGB1 P05556 3/20 0.39
ITGA4 P13612 3/20 0.39
GFER P55789 1/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 1/20 0.39
KDM4E B2RXH2 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670553 1.00 HTT (0.45) HTTSMN1; SMN2LMNAEGFRALDH1A1
SCHEMBL6972201 0.80 ITGB1 (0.66) HTTSMN1; SMN2LMNAALDH1A1NPC1
SCHEMBL6972192 0.80 ITGB1 (0.66) HTTSMN1; SMN2LMNAALDH1A1NPC1
SCHEMBL1467988 0.68 SMN1; SMN2 (0.61) HTTSMN1; SMN2LMNAEGFRALDH1A1
SCHEMBL24003686 0.68 P2RX7 (0.64) SMN1; SMN2LMNAEGFRALDH1A1NPC1
SCHEMBL6977318 0.68 ITGB1 (0.67) HTTSMN1; SMN2LMNAALDH1A1NPC1
SCHEMBL6977320 0.68 ITGB1 (0.67) HTTSMN1; SMN2LMNAALDH1A1NPC1
SCHEMBL3675077 0.68 GFER (0.57) HTTSMN1; SMN2LMNAEGFRALDH1A1
SCHEMBL6992077 0.67 SMN1; SMN2 (0.63) HTTSMN1; SMN2LMNAEGFRALDH1A1
SCHEMBL27476499 0.67 SMN1; SMN2 (0.63) HTTSMN1; SMN2LMNAEGFRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465471-B1 INHIBIT BINDING OF ALPHA 4 INTEGRINS TO THEIR LIGANDS THUS THEY ARE OF USE IN PROPHYLAXIS AND TREATMENT OF IMMUNE OR INFLAMMATORY DISORDERS CELLTECH THERAPEUTICS LIMITED (GB) 2002-10-15 US disclosed